Investors
EXPMARDS
- Income Statement
- Annual
All numbers in thousands USD
Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
Total Revenue | 3,091 | 1,535 | 1,000 | 1,022 |
Cost of Revenue | 33,084 | -- | -- | -- |
Gross Profit | 3,091 | 1,535 | -- | -- |
Operating Expenses | ||||
Research Development | 25,923 | 36,936 | 16,956 | 24,083 |
Selling General and Administrative | 7,161 | 7,310 | 6,445 | 6,026 |
Non Recurring | -- | -- | -- | -- |
Others | (3,091) | 0 | 0 | 0 |
Total Operating Expenses | 29,993 | 44,246 | 23,401 | 30,109 |
Operating Income or Loss | (29,993) | (42,711) | (22,401) | (29,087) |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (257) | (796) | (9) | (951) |
Earnings Before Interest And Taxes | (29,993) | (41,915) | (22,401) | (29,087) |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (30,371) | (42,160) | (22,333) | (29,681) |
Income Tax Expense | 435 | (28) | -- | -- |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | (30,371) | (42,193) | (22,333) | (29,681) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | (30,371) | (42,193) | (22,333) | (29,681) |
Preferred Stock And Other Adjustments | -- | 4,127 | -- | -- |
Net Income Applicable To Common Shares | (30,371) | (46,320) | (22,333) | (29,681) |